Hologic to Acquire Gen-Probe for $3.7 Billion -A Move to Create a Leading Diagnostics Franchise Focused on Women's Health -Deal Analysis form GlobalData
Summary
GlobalData’s report, “Hologic to Acquire Gen-Probe for $3.7 Billion -A Move to Create a Leading Diagnostics Franchise Focused on Women's Health” provides key insights on the deal. The report provides an analysis on the inorganic growth strategies of Hologic, Gen-Probe’s product innovations and pipeline, Hologics’s financial performance and opportunities in the molecular diagnostics market.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
Reasons to buy
Summary
GlobalData’s report, “Hologic to Acquire Gen-Probe for $3.7 Billion -A Move to Create a Leading Diagnostics Franchise Focused on Women's Health” provides key insights on the deal. The report provides an analysis on the inorganic growth strategies of Hologic, Gen-Probe’s product innovations and pipeline, Hologics’s financial performance and opportunities in the molecular diagnostics market.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Strategic rationale behind the deal including analysis on the impact of the deal on the industry.
- Qualitative analysis on Hologic’s acquisition of Gen-Probe.
- The Market penetration of Hologic in the molecular diagnostics market.
- Company profiles of Hologic, Inc. and Gen-Probe Incorporated.
Reasons to buy
- Understand the business strategy behind this deal by a medical device company to strengthen its current product portfolio and enter new product segments showing positive future growth trend.
- Design and develop your marketing and sales strategies
- Develop market expansion strategies
- Exploit M&A opportunities by identifying key areas of growth
- Make more informed business decisions from the insightful and in-depth analysis of the global regenerative medicine market
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 HOLOGIC TO ACQUIRE GEN-PROBE FOR $3.7 BILLION - A MOVE TO CREATE A LEADING DIAGNOSTICS FRANCHISE FOCUSED ON WOMEN'S HEALTH
2.1 Deal Summary
2.2 Deal Impact on Industry
2.3 Deal Rationale
2.4 Company Profiles
2.5 Analyst Commentary
3 APPENDIX
3.1 Research Methodology
3.2 Secondary Research
3.3 Primary Research
3.4 Models
3.5 Forecasts
3.6 Expert Panels
3.7 GlobalData Consulting
3.8 Contact Us
3.9 Disclaimer
LIST OF TABLES
Table 1: Key Deals Among Medical Device Manufacturers and Molecular Diagnostics Companies, 2010-2012
Table 2: Gen-Probe, Product Portfolio, Global, 2012
Table 3: Hologic, Inc., Acquisitions, 2007-2012
Table 4: Hologic, Inc., Company Snapshot
Table 5: Hologic, Inc., Business Segments Overview
Table 6: Gen-Probe Incorporated, Company Snapshot
LIST OF FIGURES
Figure 1: Hologic and Gen-Probe, Consolidation of Women’s Health Portfolio
Figure 2: Hologic and Gen-Probe, Consolidation of Women’s Health Portfolio
Figure 3: Pipeline Products of Gen-Probe, 2012
1.1 List of Tables
1.2 List of Figures
2 HOLOGIC TO ACQUIRE GEN-PROBE FOR $3.7 BILLION - A MOVE TO CREATE A LEADING DIAGNOSTICS FRANCHISE FOCUSED ON WOMEN'S HEALTH
2.1 Deal Summary
2.2 Deal Impact on Industry
2.3 Deal Rationale
2.4 Company Profiles
2.5 Analyst Commentary
3 APPENDIX
3.1 Research Methodology
3.2 Secondary Research
3.3 Primary Research
3.4 Models
3.5 Forecasts
3.6 Expert Panels
3.7 GlobalData Consulting
3.8 Contact Us
3.9 Disclaimer
LIST OF TABLES
Table 1: Key Deals Among Medical Device Manufacturers and Molecular Diagnostics Companies, 2010-2012
Table 2: Gen-Probe, Product Portfolio, Global, 2012
Table 3: Hologic, Inc., Acquisitions, 2007-2012
Table 4: Hologic, Inc., Company Snapshot
Table 5: Hologic, Inc., Business Segments Overview
Table 6: Gen-Probe Incorporated, Company Snapshot
LIST OF FIGURES
Figure 1: Hologic and Gen-Probe, Consolidation of Women’s Health Portfolio
Figure 2: Hologic and Gen-Probe, Consolidation of Women’s Health Portfolio
Figure 3: Pipeline Products of Gen-Probe, 2012
